1. Home
  2. FVRR vs GLSI Comparison

FVRR vs GLSI Comparison

Compare FVRR & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

HOLD

Current Price

$10.85

Market Cap

372.4M

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$27.05

Market Cap

327.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVRR
GLSI
Founded
2010
2006
Country
Israel
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.4M
327.2M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
FVRR
GLSI
Price
$10.85
$27.05
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$18.43
$50.00
AVG Volume (30 Days)
877.5K
102.0K
Earning Date
04-29-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.83
N/A
P/E Ratio
$22.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.67
$7.78
52 Week High
$34.13
$34.10

Technical Indicators

Market Signals
Indicator
FVRR
GLSI
Relative Strength Index (RSI) 49.49 59.92
Support Level $9.97 $20.86
Resistance Level $11.33 $30.08
Average True Range (ATR) 0.52 1.69
MACD -0.06 0.46
Stochastic Oscillator 32.46 78.15

Price Performance

Historical Comparison
FVRR
GLSI

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

Share on Social Networks: